Understanding Anthem and GLP-1 medications GLP-1 receptor agonists have transformed the weight loss landscape
It is now ready, and should be stored in the fridge when not being used
Ros team runs that pipeline for you
Participants were randomly assigned to receive retatrutide (4 mg, 9 mg, or 12 mg) or placebo by once-weekly subcutaneous injection (134, 133, 136, and 134 individuals, respectively).The researchers found that for the treatment regimen estimand, the mean change from baseline in hemoglobin A1c concentration was 1.69, 1.86, and 1.94 percent with 4, 9, and 12 mg of retatrutide, respectively, versus 0.81 percent with placebo, resulting in estimated treatment differences of 0.88, 1.04, and 1.12 percent, respectively, versus placebo